Drugs / Teprenone
Teprenone
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT05672134 | Apr 2023 → Aug 2024 | diastolic heart failure | Amsterdam UMC, location VUmc | Completed | No outcome recorded |
| Phase 43 trials | ||||||
| Phase 4 | NCT01284647 | Feb 2011 → Oct 2012 | chronic erosive gastritis | Changhai Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01190657 | May 2010 → Feb 2013 | gastric ulcer, gastritis | Eisai Inc. | Completed | No outcome recorded |
| Phase 4 | NCT00125736 | Aug 2005 → Apr 2007 | gastric ulcer | Eisai Inc. | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT07654049 | Jun 2026 → Jun 2027 expected | digestive system disorder | Second Affiliated Hospital, School of Medicine, Zhejiang University | Not yet recruiting | No outcome recorded |
| — | NCT01547559 | Jun 2007 → Nov 2014 | drug allergy | Sun Yat-sen University | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT01397448 Comparator | Jul 2011 → Mar 2013 | active peptic ulcer disease | Eisai Inc. | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Teprenone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01547559 ↗ |
| Known as | E0671 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00125736 ↗ |
| Known as | Geranylgeranylacetone | “Geranylgeranylacetone protects against small-intestinal injuries induced by diclofenac in patients with rheumatic diseases: a prospective randomized study.” PMID 25660821 ↗ Jan 2015 |
| Known as | GGA | “Geranylgeranylacetone (GGA)” NCT05672134 ↗ |
| Known as | Selbex | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01190657 ↗ |
| Known as | Teprenona | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314356 ↗ |
| Route | Oral | “One 50 mg capsule is orally administered three times daily (150 mg/day)” NCT00125736 ↗ |